Andrew T. Dailey

John William Nord Jr., MD is a Staff Physician at the George E. Wahlen VA Medical Center in Salt Lake City, UT As a primary care internist, His clinical interests include hypertension, obstructive sleep apnea, and preventative medicine. He is the sole provider at the VA who sees veterans in the post deployment intake clinic; a multidisciplinary clinic that targets veterans returning from Iraq and Afghanistan and seeks to enroll them in VA care. Dr. Nord received his undergraduate degree from the University of Miami in 2001. He completed training in medicine at the University of Utah in 2006, and went on to complete residency in Internal Medicine in 2009. Dr. Nord served as Chief Medical Resident from 2009 to 2010 at the University of Utah. Upon completion of his Chief year, he joined the faculty at the George E Wahlen VA Medical Center. He is currently board certified in Internal Medicine.

Kelsey Juster-Switlyk, MD, is an assistant professor in the Division of Neuromuscular Medicine within the Department of Neurology at the University of Utah. She hails from Portland Oregon, studied anthropology at the University of Victoria, BC, before obtaining her MD at Rosalind Franklin University of Medical Sciences in Chicago. She completed her internship, residency and fellowship under the mentorship of Dr. Gordon Smith at the University of Utah, where she developed a passion for academic medicine and education. Her academic interests include cancer and chemotherapy related neuromuscular...

Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division. Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin...